SCHEMBL30064489

SCHEMBL30064489

Cc1cc(-c2n[nH]c3ncc(-c4ccc(C5CCNCC5)cc4)cc23)ccc1CNC(=O)c1noc(C(C)(C)C)n1

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 19/20 0.45
▸ LCK P06239 1/20 0.39
▸ PLAT P00750 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23816017 1.00 BTK (0.45) BTKLCKPLAT
SCHEMBL23816197 0.92 BTK (0.52) BTKLCK
Hydrochloric Acid SCHEMBL30063459 0.92 BTK (0.52) BTKLCK
Hydrochloric Acid SCHEMBL26114720 0.92 BTK (0.52) BTKLCK
SCHEMBL30063476 0.87 BTK (0.44) BTKLCKPLAT
SCHEMBL23816068 0.87 BTK (0.44) BTKLCKPLAT
SCHEMBL26114595 0.87 BTK (0.46) BTKLCK
Hydrochloric Acid SCHEMBL30064492 0.87 BTK (0.46) BTKLCK
Hydrochloric Acid SCHEMBL26113873 0.87 BTK (0.46) BTKLCK
SCHEMBL23816261 0.82 BTK (0.44) BTKLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118791426-A (R) -glutarimide CRBN ligands and methods of use 百济神州有限公司 2024-10-18 — — CN disclosed
EP-4359403-A1 (R) -GLUTARIMIDE CRBN LIGANDS AND METHODS OF USE BeiGene Switzerland GmbH (CH) 2024-05-01 — — EP disclosed
WO-2022268052-A9 (R) -GLUTARIMIDE CRBN LIGANDS AND METHODS OF USE BEIGENE, LTD. (KY) 2023-08-17 — — WO disclosed
WO-2022268052-A1 (R) -GLUTARIMIDE CRBN LIGANDS AND METHODS OF USE BEIGENE, LTD. (KY) 2022-12-29 — — WO disclosed
CN-115335376-A Degradation of Bruton's Tyrosine Kinase (BTK) by conjugation of BTK inhibitor with E3 ligase ligand and methods of use thereof 百济神州有限公司 2022-11-11 — — CN disclosed
Send feedback